In NSCLC, SNHG3 promoted the proliferation, migration, and invasion of NSCLC cells by activating the TGF-β and IL-6/JAK2/STAT3 signaling pathways [20]. The gene discussed is JAK2; the disease is non-small cell lung carcinoma.